Author:
Hufnagel Markus,Kallinich Tilmann
Publisher
Springer Berlin Heidelberg
Reference25 articles.
1. Aeschlimann FA et al (2018) A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognized NF-kB-mediated autoinflammatory disease. Ann Rheum Dis 77:728–735
2. Direskeneli H, Mumcu G (2010) A possible decline in the incidence and the severity of Behçet’s disease: implications for an infectious etiology and oral health. Clin Exp Rheumatol 28:S86–S90
3. Gül A (2019) Behçet disease. In: Haskes PJ, Laxer RM, Simon A (Hrsg.), Textbook of autoinflammation. Springer Nature, Berlin, S 647–666
4. Gül A, Inanç M, Öcal L, Aral O, Koniçe M (2000) Familial aggregation of Behçet’s disease in Turkey. Ann Rheum Dis 59:622–625
5. Hatemi G et al (2015) Apremilast for Behçet’s syndrome – a phase 2, placebo-controlled study. N Engl J Med 372:1510–1518